359 related articles for article (PubMed ID: 12626389)
1. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
2. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
[TBL] [Abstract][Full Text] [Related]
3. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D
Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
[TBL] [Abstract][Full Text] [Related]
6. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
7. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
Itoh N; Sakaue S; Nakagawa H; Kurogochi M; Ohira H; Deguchi K; Nishimura S; Nishimura M
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1069-77. PubMed ID: 17666489
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and nosology of glycanosis CDG ("carbohydrate deficient glycoprotein syndrome")].
Heyne K; Weidinger S
Monatsschr Kinderheilkd; 1992 Nov; 140(11):822-7. PubMed ID: 1470190
[TBL] [Abstract][Full Text] [Related]
10. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
13. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
14. Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis.
Kleinert P; Kuster T; Arnold D; Jaeken J; Heizmann CW; Troxler H
Proteomics; 2007 Jan; 7(1):15-22. PubMed ID: 17152094
[TBL] [Abstract][Full Text] [Related]
15. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.
Saldova R; Fan Y; Fitzpatrick JM; Watson RW; Rudd PM
Glycobiology; 2011 Feb; 21(2):195-205. PubMed ID: 20861084
[TBL] [Abstract][Full Text] [Related]
16. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
de Koning TJ; Dorland L; van Diggelen OP; Boonman AM; de Jong GJ; van Noort WL; De Schryver J; Duran M; van den Berg IE; Gerwig GJ; Berger R; Poll-The BT
Biochem Biophys Res Commun; 1998 Apr; 245(1):38-42. PubMed ID: 9535779
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
18. Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).
Van Dijk W; Koeleman C; Van het Hof B; Poland D; Jakobs C; Jaeken J
FEBS Lett; 2001 Apr; 494(3):232-5. PubMed ID: 11311246
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.
Morelle W; Flahaut C; Michalski JC; Louvet A; Mathurin P; Klein A
Glycobiology; 2006 Apr; 16(4):281-93. PubMed ID: 16339757
[TBL] [Abstract][Full Text] [Related]
20. Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.
Mills P; Mills K; Clayton P; Johnson A; Whitehouse D; Winchester B
Biochem J; 2001 Oct; 359(Pt 2):249-54. PubMed ID: 11583570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
